Senotherapeutic Drugs: A New Avenue for Skincare?

Ben P Lee1, Lorna W Harries1

  • 1From SENISCA; and University of Exeter Medical School, University of Exeter.

Abstract

Insights

Cellular senescence drives skin aging. Emerging senotherapeutic interventions, including senolytics and senomorphics, offer new ways to combat aging by targeting senescent cells and improving mRNA processing for healthier skin.

Area of Science:

  • Gerontology
  • Dermatology
  • Molecular Biology

Background:

  • Skin aging is a visible sign of systemic aging processes.
  • Cellular senescence, the accumulation of aging cells, is a key driver of aging.
  • Hallmarks of aging include cellular senescence and dysregulated mRNA processing.

Purpose of the Study:

  • To review the role of cellular senescence in skin aging.
  • To discuss emerging senotherapeutic interventions for skin aging.
  • To explore oligonucleotide therapeutics for manipulating mRNA processing.

Main Methods:

  • Literature review of cellular senescence and aging hallmarks.
  • Analysis of senolytic and senomorphic therapeutic strategies.
  • Discussion of oligonucleotide therapeutics for mRNA processing.

Main Results:

  • Cellular senescence significantly contributes to skin aging.
  • Senolytics and senomorphics are promising interventions.
  • Oligonucleotide therapeutics offer a novel approach to target mRNA processing.

Conclusions:

  • Senotherapeutics represent a revolutionary approach to treating skin aging.
  • Targeting cellular senescence and mRNA processing can improve skin health.
  • Senotherapies are emerging as a new class of skincare interventions.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
523
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.9K
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.3K